logo
explain how to read the page

The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers
Active 4
  • 1
    Kotchie, Robert
    Born in January 1979
    Individual (13 offsprings)
    Officer
    icon of calendar 2023-08-31 ~ now
    OF - Director → CIF 0
  • 2
    Park, Graham Russell
    Born in September 1974
    Individual (16 offsprings)
    Officer
    icon of calendar 2023-08-31 ~ now
    OF - Director → CIF 0
  • 3
    STEVTON (NO.218) LIMITED - 2001-12-04
    JTC MAYFAIR LIMITED - 2006-07-19
    icon of addressThe Scalpel, 18th Floor, 52 Lime Street, London, United Kingdom
    Active Corporate (8 parents, 359 offsprings)
    Equity (Company account)
    Retained earnings (accumulated losses)
    2,264,414 GBP2024-12-31
    Officer
    icon of calendar 2023-08-31 ~ now
    OF - Secretary → CIF 0
  • 4
    QUINTILES LIMITED - 2017-11-03
    QUINTILES SCOTLAND LIMITED - 2000-12-29
    icon of address3, Forbury Place, 23 Forbury Road, Reading, United Kingdom
    Active Corporate (7 parents, 45 offsprings)
    Person with significant control
    icon of calendar 2024-12-02 ~ now
    PE - Ownership of voting rights - 75% or more → CIF 0
    PE - Ownership of shares – 75% or more → CIF 0
Ceased 8
  • 1
    Carter, Ralph Trevor Jacobus, Dr
    Physician born in March 1961
    Individual (2 offsprings)
    Officer
    icon of calendar 2011-10-04 ~ 2023-08-31
    OF - Director → CIF 0
    Dr Ralph Trevor Jacobus Carter
    Born in March 1961
    Individual (2 offsprings)
    Person with significant control
    icon of calendar 2016-04-06 ~ 2021-07-01
    PE - Ownership of shares – More than 50% but less than 75% → CIF 0
  • 2
    Finlay, Ross Frazer
    Chief Financial Officer born in March 1971
    Individual (13 offsprings)
    Officer
    icon of calendar 2023-02-13 ~ 2023-08-31
    OF - Director → CIF 0
  • 3
    Nakielny, Joanna Margaret, Dr
    Individual
    Officer
    icon of calendar 2011-10-04 ~ 2014-11-25
    OF - Secretary → CIF 0
  • 4
    Sharma, Sangeeta
    Medical Director born in August 1972
    Individual
    Officer
    icon of calendar 2021-07-01 ~ 2022-06-23
    OF - Director → CIF 0
  • 5
    Garlick, Robert James
    Cfo born in October 1976
    Individual (1 offspring)
    Officer
    icon of calendar 2022-07-19 ~ 2022-12-14
    OF - Director → CIF 0
  • 6
    Donoghue, Stella Mary
    Director born in May 1966
    Individual (4 offsprings)
    Officer
    icon of calendar 2021-07-01 ~ 2023-08-31
    OF - Director → CIF 0
  • 7
    Pugh, Tessa Louise
    Born in February 1973
    Individual
    Officer
    icon of calendar 2013-01-01 ~ 2023-08-31
    OF - Director → CIF 0
    Mrs Tessa Louise Pugh
    Born in February 1973
    Individual
    Person with significant control
    icon of calendar 2016-04-06 ~ 2021-07-01
    PE - Ownership of shares – More than 25% but not more than 50% → CIF 0
  • 8
    icon of address3, Forbury Place, 23 Forbury Road, Reading, England
    Active Corporate (4 parents)
    Profit/Loss (Company account)
    -871,760 GBP2023-01-01 ~ 2023-12-31
    Person with significant control
    2021-07-01 ~ 2024-12-02
    PE - Right to appoint or remove directors → CIF 0
    PE - Ownership of shares – 75% or more → CIF 0
    PE - Ownership of voting rights - 75% or more → CIF 0
parent relation
Company in focus

PHARMAREVIEW LIMITED

Standard Industrial Classification
74909 - Other Professional, Scientific And Technical Activities N.e.c.
Brief company account
Average Number of Employees
732024-01-01 ~ 2024-12-31
942023-01-01 ~ 2023-12-31
Turnover/Revenue
10,516,724 GBP2024-01-01 ~ 2024-12-31
10,548,332 GBP2023-01-01 ~ 2023-12-31
Cost of Sales
-71,075 GBP2024-01-01 ~ 2024-12-31
-262,015 GBP2023-01-01 ~ 2023-12-31
Gross Profit/Loss
10,445,649 GBP2024-01-01 ~ 2024-12-31
10,286,317 GBP2023-01-01 ~ 2023-12-31
Administrative Expenses
-5,245,969 GBP2024-01-01 ~ 2024-12-31
-8,155,381 GBP2023-01-01 ~ 2023-12-31
Operating Profit/Loss
5,199,680 GBP2024-01-01 ~ 2024-12-31
2,130,936 GBP2023-01-01 ~ 2023-12-31
Other Interest Receivable/Similar Income (Finance Income)
1,859 GBP2024-01-01 ~ 2024-12-31
9,170 GBP2023-01-01 ~ 2023-12-31
Profit/Loss on Ordinary Activities Before Tax
5,201,539 GBP2024-01-01 ~ 2024-12-31
2,140,106 GBP2023-01-01 ~ 2023-12-31
Profit/Loss
5,215,277 GBP2024-01-01 ~ 2024-12-31
2,009,335 GBP2023-01-01 ~ 2023-12-31
Intangible Assets
26,323 GBP2024-12-31
13,272 GBP2023-12-31
Property, Plant & Equipment
64,394 GBP2023-12-31
Fixed Assets
26,323 GBP2024-12-31
77,666 GBP2023-12-31
Debtors
Current
3,498,642 GBP2024-12-31
4,068,333 GBP2023-12-31
Cash at bank and in hand
5,290,701 GBP2024-12-31
1,981,586 GBP2023-12-31
Current Assets
8,789,343 GBP2024-12-31
6,049,919 GBP2023-12-31
Creditors
Current, Amounts falling due within one year
-1,017,362 GBP2023-12-31
Net Current Assets/Liabilities
6,763,007 GBP2024-12-31
5,032,557 GBP2023-12-31
Total Assets Less Current Liabilities
6,789,330 GBP2024-12-31
5,110,223 GBP2023-12-31
Net Assets/Liabilities
6,789,330 GBP2024-12-31
5,110,223 GBP2023-12-31
Equity
Called up share capital
150 GBP2024-12-31
150 GBP2023-12-31
150 GBP2023-01-01
Retained earnings (accumulated losses)
6,789,180 GBP2024-12-31
5,110,073 GBP2023-12-31
3,100,738 GBP2023-01-01
Equity
6,789,330 GBP2024-12-31
5,110,223 GBP2023-12-31
3,100,888 GBP2023-01-01
Profit/Loss
Retained earnings (accumulated losses)
5,215,277 GBP2024-01-01 ~ 2024-12-31
2,009,335 GBP2023-01-01 ~ 2023-12-31
Comprehensive Income/Expense
Retained earnings (accumulated losses)
5,215,277 GBP2024-01-01 ~ 2024-12-31
2,009,335 GBP2023-01-01 ~ 2023-12-31
Comprehensive Income/Expense
5,215,277 GBP2024-01-01 ~ 2024-12-31
2,009,335 GBP2023-01-01 ~ 2023-12-31
Dividends Paid
Retained earnings (accumulated losses)
-3,536,170 GBP2024-01-01 ~ 2024-12-31
Dividends Paid
-3,536,170 GBP2024-01-01 ~ 2024-12-31
Equity - Income/Expense Recognised Directly
Retained earnings (accumulated losses)
-3,536,170 GBP2024-01-01 ~ 2024-12-31
Equity - Income/Expense Recognised Directly
-3,536,170 GBP2024-01-01 ~ 2024-12-31
Property, Plant & Equipment - Depreciation rate used
Furniture and fittings
202024-01-01 ~ 2024-12-31
Computers
202024-01-01 ~ 2024-12-31
Audit Fees/Expenses
27,000 GBP2024-01-01 ~ 2024-12-31
15,000 GBP2023-01-01 ~ 2023-12-31
Wages/Salaries
4,157,864 GBP2024-01-01 ~ 2024-12-31
4,973,810 GBP2023-01-01 ~ 2023-12-31
Social Security Costs
356,076 GBP2024-01-01 ~ 2024-12-31
546,826 GBP2023-01-01 ~ 2023-12-31
Staff Costs/Employee Benefits Expense
4,568,643 GBP2024-01-01 ~ 2024-12-31
5,603,103 GBP2023-01-01 ~ 2023-12-31
Director Remuneration
415,482 GBP2023-01-01 ~ 2023-12-31
Deferred Tax Expense/Credit Relating to Origination/Reversal Timing Differences
8,059 GBP2024-01-01 ~ 2024-12-31
-53,451 GBP2023-01-01 ~ 2023-12-31
Tax Expense/Credit at Applicable Tax Rate
1,300,385 GBP2024-01-01 ~ 2024-12-31
503,353 GBP2023-01-01 ~ 2023-12-31
Dividends Paid on Shares
3,536,170 GBP2024-01-01 ~ 2024-12-31
Intangible Assets - Gross Cost
Development expenditure
1,012 GBP2024-12-31
1,012 GBP2023-12-31
Computer software
51,325 GBP2024-12-31
16,520 GBP2023-12-31
Intangible Assets - Gross Cost
52,337 GBP2024-12-31
17,532 GBP2023-12-31
Intangible Assets - Accumulated Amortisation & Impairment
Development expenditure
1,012 GBP2024-12-31
1,012 GBP2023-12-31
Intangible Assets - Accumulated Amortisation & Impairment
26,014 GBP2024-12-31
4,260 GBP2023-12-31
Intangible Assets - Increase From Amortisation Charge for Year
21,754 GBP2024-01-01 ~ 2024-12-31
Property, Plant & Equipment - Gross Cost
Furniture and fittings
314,308 GBP2023-12-31
Property, Plant & Equipment - Other Disposals
Furniture and fittings
-314,308 GBP2024-01-01 ~ 2024-12-31
Property, Plant & Equipment - Accumulated Depreciation (Not Including Impairment)
Furniture and fittings
249,914 GBP2023-12-31
Property, Plant & Equipment - Increase From Depreciation Charge for Year
Furniture and fittings, Owned/Freehold
64,394 GBP2024-01-01 ~ 2024-12-31
Property, Plant & Equipment - Other Disposals/Decrease in Depreciation & Impairment
Furniture and fittings
-314,308 GBP2024-01-01 ~ 2024-12-31
Property, Plant & Equipment
Furniture and fittings
64,394 GBP2023-12-31
Trade Debtors/Trade Receivables
Current
1,931,891 GBP2024-12-31
2,070,774 GBP2023-12-31
Amounts Owed by Group Undertakings
Current
244,111 GBP2024-12-31
1,722,472 GBP2023-12-31
Other Debtors
Current
261,339 GBP2024-12-31
189,544 GBP2023-12-31
Prepayments/Accrued Income
Current
1,060,747 GBP2024-12-31
76,930 GBP2023-12-31
Debtors - Deferred Tax Asset
Current
554 GBP2024-12-31
8,613 GBP2023-12-31
Cash and Cash Equivalents
5,290,701 GBP2024-12-31
1,981,586 GBP2023-12-31
Trade Creditors/Trade Payables
Current
15,266 GBP2024-12-31
95,986 GBP2023-12-31
Amounts owed to group undertakings
Current
1,174,996 GBP2024-12-31
Taxation/Social Security Payable
Current
191,188 GBP2024-12-31
498,908 GBP2023-12-31
Other Creditors
Current
249,125 GBP2024-12-31
6,084 GBP2023-12-31
Accrued Liabilities/Deferred Income
Current
395,761 GBP2024-12-31
416,384 GBP2023-12-31
Creditors
Current
2,026,336 GBP2024-12-31
1,017,362 GBP2023-12-31
Net Deferred Tax Liability/Asset
554 GBP2024-12-31
8,613 GBP2023-12-31
Profit/Loss - Increase/Decrease in Net Deferred Tax Liability from Amount Recognised
-8,059 GBP2024-01-01 ~ 2024-12-31
Number of Shares Issued (Fully Paid)
Class 1 ordinary share
150 shares2024-12-31
150 shares2023-12-31
Par Value of Share
Class 1 ordinary share
1.002024-01-01 ~ 2024-12-31
Future Minimum Lease Payments Under Non-cancellable Operating Leases
Amounts falling due within one year
73,448 GBP2024-12-31
174,563 GBP2023-12-31
Between one and five year
73,448 GBP2023-12-31
Future Minimum Lease Payments Under Non-cancellable Operating Leases
73,448 GBP2024-12-31
248,011 GBP2023-12-31
  • PHARMAREVIEW LIMITED
    Info
    Registered number 07796206
    icon of address3 Forbury Place, 23 Forbury Road, Reading RG1 3JH
    PRIVATE LIMITED COMPANY incorporated on 2011-10-04 (14 years 2 months). The company status is Active.
    The last date of confirmation statement was made at 2025-02-04
    CIF 0
child relation
Offspring entities and appointments
Active 0
  • Not found in our database.

qrcode

Privacy notice

Terms and conditions

The content of this website is protected by AgonGuard.

© 2022-2025 Polylogarithmic Technology Ltd (Registered in England and Wales No. 14256313). All rights reserved.

Contains public sector information retrieved at 12 November 2025 and licensed under the Open Government Licence v3.0.